giovedì, 26 novembre 2020
Medinews
15 Giugno 2018

FDA approves first generic versions of Suboxone sublingual film, which may increase access to treatment for opioid dependence

June 14, 2018 – The U.S. Food and Drug Administration today approved the first generic versions of Suboxone (buprenorphine and naloxone) sublingual film (applied under the tongue) for the treatment of opioid dependence. “The FDA is taking new steps to advance the development of improved treatments for opioid use disorder, and to make sure these medicines are accessible to the patients who need them That includes promoting the development … (leggi tutto)

TORNA INDIETRO